Patent · US Active

Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells

US10005820B2 · kind B2 · utility

7Cited by
39References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2012
Grant dateJun 26, 2018
Priority date
Expiry dateFeb 15, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/74
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present application relates to the use of bacterial minicells as targeted delivery agents in vivo and in vitro. Described herein are genetically engineered eubacterial minicells designed to preferentially target and deliver therapeutically relevant agents using a minicell surface coupling molecule capable of binding and displaying antibodies or other Fc-containing targeting moiety fusions and conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.